Comparison of 5‐Fluorouracil/Leucovorin and Capecitabine as Adjuvant Therapies in Biliary Tract Cancer

Documenti analoghi

• Efficacy of Biliary Brush Cytology With Rapid On‐Site Cytological Evaluation for the Detection of Malignant Biliary Strictures
  di: Il Sang Shin, et al.
  Pubblicazione: (2025)
• Long‐Term Surveillance for Pancreatic Carcinoma Among Patients With Branch‐Duct Intraductal Papillary Mucinous Neoplasms
  di: Gaeun Lee, et al.
  Pubblicazione: (2025)
• Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
  di: Jungnam Lee, et al.
  Pubblicazione: (2024)
• When Matching Misses the Mark: Reassessing Capecitabine's Reported Benefit in Resected Biliary Tract Cancer
  di: Raza ur Rehman, et al.
  Pubblicazione: (2025)
• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  di: Han Ah. Lee, et al.
  Pubblicazione: (2025)